Research and Development (R&D)

Details and Analysis of President Biden’s American Jobs Plan

June 4, 2021

CBO Report on R&D and Tax Policy in the Pharmaceutical Industry

May 25, 2021

Tax Policy Ideas in the Republican Study Committee Budget

May 19, 2021

Reviewing the Federal Tax Treatment of Research & Development Expenses

April 13, 2021

Biden’s Corporate Minimum Book Tax Narrows, but Problems and Uncertainties Remain

April 13, 2021

Denying Deductions for Pharma Ads Is Bad Tax Policy

April 12, 2021

The Balancing Act of GILTI and FDII

April 7, 2021

Tax Subsidies for R&D Spending and Patent Boxes in OECD Countries

March 17, 2021

Tax Policy Improvements Needed to Help Industries through the Semiconductor Shortage

March 16, 2021

The European Commission and the Taxation of the Digital Economy

February 4, 2021

Poland Borrows an Idea from Estonia’s Tax System, but Misses the Point

December 2, 2020

Outlining a Path for Tax Policy Compromises

December 1, 2020

Patent Box Regimes in Europe

November 26, 2020

Increasing the Tax Burden on Capital Investment and Automation Hurts Workers

November 12, 2020

Prospects for Federal Tax Policy After the 2020 Election

November 10, 2020

Reviewing the Commitment to American GROWTH Act

October 14, 2020

Biden’s Plan to Boost Research and Development Should Include Cancellation of Upcoming R&D Amortization

July 13, 2020

Tax Policy After Coronavirus: Clearing a Path to Economic Recovery

April 22, 2020

Key Tax Provisions from the UK’s 2020 Budget

March 11, 2020

Switzerland Referendum Approves Tax Reform

June 5, 2019